<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Wingfield Works - pharmacy law and ethics, pharmacy education and training, expert legal advice. &#187; Consultation</title>
	<atom:link href="http://www.joywingfield.co.uk/category/consultation/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.joywingfield.co.uk</link>
	<description>pharmacy law and ethics, pharmacy education and training, expert legal advice on pharmacy practice.</description>
	<lastBuildDate>Thu, 02 Feb 2012 09:43:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>CHRE consultation: Standards for NHS governance</title>
		<link>http://www.joywingfield.co.uk/2012/01/19/chre-consultation-standards-for-nhs-governance/</link>
		<comments>http://www.joywingfield.co.uk/2012/01/19/chre-consultation-standards-for-nhs-governance/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 09:42:59 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=757</guid>
		<description><![CDATA[The CHRE (Council for Regulatory Healthcare Excellence) is consulting on draft standards for members of NHS Boards and governing bodies in England. This is a further part of the Government&#8217;s NHS reforms to establish greater accountability and standards of behaviour and competence in those who manage the NHS in England. Consultation closes on 10th April [...]]]></description>
			<content:encoded><![CDATA[<p>The CHRE (Council for Regulatory Healthcare Excellence) is consulting on <a href="http://www.chre.org.uk/satellite/413">draft standards</a> for members of NHS Boards and governing bodies in England. This is a further part of the Government&#8217;s NHS reforms to establish greater accountability and standards of behaviour and competence in those who manage the NHS in England. Consultation closes on 10th April 2012 </p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2012/01/19/chre-consultation-standards-for-nhs-governance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CHRE consultation on efficient regulation</title>
		<link>http://www.joywingfield.co.uk/2011/12/31/chre-consultation-on-efficient-regulation/</link>
		<comments>http://www.joywingfield.co.uk/2011/12/31/chre-consultation-on-efficient-regulation/#comments</comments>
		<pubDate>Sat, 31 Dec 2011 14:57:31 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=755</guid>
		<description><![CDATA[The Council for Healthcare Regulatory Excellence (CHRE) has issued a &#8220;call for ideas&#8221; on cost effectiveness and efficiency in health professional regulation. This is prompted by the Government white paper of February 2011 &#8220;Enabling Excellence: autonomy and accountability for health care workers, etc&#8230;&#8221;. Consultation closes on 19th January 2012.]]></description>
			<content:encoded><![CDATA[<p>The Council for Healthcare Regulatory Excellence (CHRE) has issued a &#8220;<a href="http://www.chre.org.uk/satellite/414/">call for ideas</a>&#8221; on cost effectiveness and efficiency in health professional regulation. This is prompted by the Government white paper of February 2011 &#8220;Enabling Excellence: autonomy and accountability for health care workers, etc&#8230;&#8221;. Consultation closes on 19th January 2012.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/12/31/chre-consultation-on-efficient-regulation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Implementing Pharmacovigilance Directive</title>
		<link>http://www.joywingfield.co.uk/2011/12/15/implementing-pharmacovigilance-directive/</link>
		<comments>http://www.joywingfield.co.uk/2011/12/15/implementing-pharmacovigilance-directive/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 09:40:02 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Law News]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=752</guid>
		<description><![CDATA[The MHRA has published a consultation (MLX 374) on draft regulations to implement Directive 2010/84/EU on pharmacovigilance. These regulations will form part 11 of the current draft consolidated medicines regulations (MLX 375 below) to be enacted under the European Communities Act 1972. Consultation closes 28th February 2012]]></description>
			<content:encoded><![CDATA[<p>The MHRA has published a <a href="http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON137667">consultation</a> (MLX 374) on draft regulations to implement Directive 2010/84/EU on pharmacovigilance. These regulations will form part 11 of the current draft consolidated medicines regulations (MLX 375 below) to be enacted under the European Communities Act 1972. Consultation closes 28th February 2012</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/12/15/implementing-pharmacovigilance-directive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on second PNA regulations</title>
		<link>http://www.joywingfield.co.uk/2011/11/04/consultation-on-second-pna-regulations/</link>
		<comments>http://www.joywingfield.co.uk/2011/11/04/consultation-on-second-pna-regulations/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 13:00:38 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Law News]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=732</guid>
		<description><![CDATA[The DH has issued a consultation on a further set of regulations to implement the Health Act 2009 provisions regarding Pharmaceutical Needs Assessments (PNAs). These include removal of three (not &#8220;distance selling&#8221;) of the current exemptions to control of entry, notably the &#8220;100 hour exemption&#8221;. The consultation also covers powers to take remedial action over [...]]]></description>
			<content:encoded><![CDATA[<p>The DH has issued a <a href="http://www.dh.gov.uk/en/Consultations/Liveconsultations/DH_130510">consultation</a> on a further set of regulations to implement the Health Act 2009 provisions regarding Pharmaceutical Needs Assessments (PNAs). These include removal of three (not &#8220;distance selling&#8221;) of the current exemptions to control of entry, notably the &#8220;100 hour exemption&#8221;. The consultation also covers powers to take remedial action over breach of terms of service and poor performance. Consultation closes 25th January 2012.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/11/04/consultation-on-second-pna-regulations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on medicines regulations</title>
		<link>http://www.joywingfield.co.uk/2011/10/25/consultation-on-medicines-regulations/</link>
		<comments>http://www.joywingfield.co.uk/2011/10/25/consultation-on-medicines-regulations/#comments</comments>
		<pubDate>Tue, 25 Oct 2011 16:20:14 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Law News]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=729</guid>
		<description><![CDATA[MHRA has issued a consultation (MLX 375) on draft consolidated medicines regulations and proposed policy changes. Consultation closes 17th January 2012]]></description>
			<content:encoded><![CDATA[<p>MHRA has issued a <a href="http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON132054">consultatio</a>n (MLX 375) on draft consolidated medicines regulations and proposed policy changes. Consultation closes 17th January 2012 </p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/10/25/consultation-on-medicines-regulations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on GPhC Guidance</title>
		<link>http://www.joywingfield.co.uk/2011/10/15/consultation-on-gphc-guidance/</link>
		<comments>http://www.joywingfield.co.uk/2011/10/15/consultation-on-gphc-guidance/#comments</comments>
		<pubDate>Sat, 15 Oct 2011 09:00:08 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=737</guid>
		<description><![CDATA[The GPhC has issued draft guidance for consultation on four topics: consent, confidentiality, raising concerns and maintaining proper professional boundaries. Consultation closes on 15th December 2011.]]></description>
			<content:encoded><![CDATA[<p>The GPhC has issued <a href="http://www.pharmacyregulation.org/get-involved/taking-view">draft guidance</a> for consultation on four topics: consent, confidentiality, raising concerns and maintaining proper professional boundaries. Consultation closes on 15th December 2011.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/10/15/consultation-on-gphc-guidance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on NHS Duty of Candour</title>
		<link>http://www.joywingfield.co.uk/2011/10/13/consultation-on-nhs-duty-of-candour/</link>
		<comments>http://www.joywingfield.co.uk/2011/10/13/consultation-on-nhs-duty-of-candour/#comments</comments>
		<pubDate>Thu, 13 Oct 2011 09:12:06 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=721</guid>
		<description><![CDATA[The DH has announced a consultation on a &#8220;duty of candour&#8221; (a duty to be open with patients when things go wrong with their healthcare) on NHS providers. The document covers providers in the managed service; further consultation may follow on amending standard contracts for family health care providers. Consultation closes 2nd January 2012]]></description>
			<content:encoded><![CDATA[<p>The DH has announced a <a href="http://www.dh.gov.uk/en/Consultations/Liveconsultations/DH_130400">consultation</a> on a &#8220;duty of candour&#8221; (a duty to be open with patients when things go wrong with their healthcare) on NHS providers. The document covers providers in the managed service; further consultation may follow on amending standard contracts for family health care providers. Consultation closes 2nd January 2012</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/10/13/consultation-on-nhs-duty-of-candour/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on extended independent prescribing</title>
		<link>http://www.joywingfield.co.uk/2011/09/16/consultation-on-extended-independent-prescribing/</link>
		<comments>http://www.joywingfield.co.uk/2011/09/16/consultation-on-extended-independent-prescribing/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 10:32:15 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Law News]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=713</guid>
		<description><![CDATA[The DH has published consultations on extending independent prescribing to physiotherapists and podiatrists. A number of options are proposed, including extending authority to mix licensed medicines prior to administartion and prescribing independently from a limited list of controlled drugs. Both consultations close on 8th December 2011.]]></description>
			<content:encoded><![CDATA[<p>The DH has published consultations on extending independent prescribing to <a href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_130042.pdf">physiotherapists</a> and <a href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_130031.pdf">podiatrists</a>. A number of options are proposed, including extending authority to mix licensed medicines prior to administartion and prescribing independently from a limited list of controlled drugs. Both consultations close on 8th December 2011.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/09/16/consultation-on-extended-independent-prescribing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on RPS regulations to admit scientists</title>
		<link>http://www.joywingfield.co.uk/2011/08/07/consultation-on-rps-regulations-to-admit-scientists/</link>
		<comments>http://www.joywingfield.co.uk/2011/08/07/consultation-on-rps-regulations-to-admit-scientists/#comments</comments>
		<pubDate>Sun, 07 Aug 2011 16:02:29 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=707</guid>
		<description><![CDATA[The RPS has published a consultation amending their regulations to admit pharmaceutical scientists. Essentially the changes are to admit &#8220;applicants holding, at least, a bachelor degree (or its equivalent), in a subject relevant to the pharmaceutical sciences, and working in the basic or applied sciences, or the social sciences, impinging on the discovery, development, delivery, [...]]]></description>
			<content:encoded><![CDATA[<p>The RPS has published a <a href="http://www.rpharms.com/about-us-pdfs/propamendregulationsrpsgazetted110806.pdf">consultation</a> amending their regulations to admit pharmaceutical scientists. Essentially the changes are to admit &#8220;applicants holding, at least, a bachelor degree (or its equivalent), in a subject relevant to the pharmaceutical sciences, and working in the basic or applied sciences, or the social sciences, impinging on the discovery, development, delivery, quality, safety, efficacy, regulation or usage of medicines and their educational development in all its many aspects&#8221; and allow them to use the letters SRPharmS. Consultation closes 4th October 2011</p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/08/07/consultation-on-rps-regulations-to-admit-scientists/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consultation on changes to MDA regs</title>
		<link>http://www.joywingfield.co.uk/2011/08/07/consultation-on-changes-to-mda-regs/</link>
		<comments>http://www.joywingfield.co.uk/2011/08/07/consultation-on-changes-to-mda-regs/#comments</comments>
		<pubDate>Sun, 07 Aug 2011 15:37:11 +0000</pubDate>
		<dc:creator>joywingfield</dc:creator>
				<category><![CDATA[Consultation]]></category>
		<category><![CDATA[Law News]]></category>
		<category><![CDATA[Pharmacy News]]></category>

		<guid isPermaLink="false">http://www.joywingfield.co.uk/?p=703</guid>
		<description><![CDATA[The Home Office has published a consultation on proposals to amend the 2001 regulations made under the Misuse of Drugs Act. The document also covers proposals not to implement (at least yet) two outstanding Shipman Inquiry recommendations: standardised requisition forms for all health professionals and a mandatory requirement to keep a running balance in the [...]]]></description>
			<content:encoded><![CDATA[<p>The Home Office has published a <a href="http://www.homeoffice.gov.uk/publications/about-us/consultations/misuse-drugs-regulations/">consultation </a>on proposals to amend the 2001 regulations made under the Misuse of Drugs Act. The document also covers proposals<br />
<strong>not </strong>to implement (at least yet) two outstanding Shipman Inquiry recommendations: standardised requisition forms for all health professionals and a mandatory requirement to keep a running balance in the CD register. Consultation closes 28th October 2011 </p>
]]></content:encoded>
			<wfw:commentRss>http://www.joywingfield.co.uk/2011/08/07/consultation-on-changes-to-mda-regs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

